ARCHIVES

Gregory Reaman Named Associate Director of FDA Office of Oncology Drug Products

This article is from The Cancer Letter archive.

Vol. 37 No. 22 | June 3, 2011

Download PDF Visit The Full Archive

Related Articles

US Sues St. Luc Hospital For Grant Funds, Expenses Of Data Reanalysis, Investigation

June 9, 1995

Cost of Care: Medicare Patients Charged More In Outpatient Care Settings

November 1, 2013

Older Women More Likely To Receive Lower Chemotherapy Doses, Study Finds

August 28, 2009

Former NCI Executive Lands Key Senate Staff Position

February 4, 1977

GAO Offers Two Suggestions For Plant Screening

April 4, 1980

Healy Saw Scripps Issue as Way To Revisit Conflict Of Interest

March 19, 1993